News

Topotecan for Injection is indicated for small cell lung cancer sensitive disease after failure of first-line chemotherapy, and is also indicated for use in combination therapy with Cisplatin

Norton Healthcare said the tie up will allow the company to aggregate and mine data in an efficient manner and will assist the Louisville, Ky.-based healthcare system in

AT-101 and AT-406 are both oral small molecules that trigger apoptosis (programmed cell death) at different points in the apoptosis pathways. As per the terms of the agreements,

As per the agreement, Baxter will exclusively license to Takeda its proprietary Vero cell-based influenza vaccine technology for the Japanese market. The companies will jointly pursue development and

Hybrigenics said that the transaction follows the successful completion of Phase IIa clinical tolerance study of oral inecalcitol in hormone-refractory prostate cancer patients. The first payment of EUR600,000

The marketing of FatigFix is a collaboration between Chrysalis and the technology holder Phynova Group, a UK company developing prescription as well as OTC drugs for healthcare and

The study revealed that patients receiving Firazyr experienced significantly faster time to onset of symptom relief from HAE symptoms, compared to those receiving placebo. Firazyr provided a highly

Daiichi Sankyo said that the Engage AF-TIMI 48 study began enrollment in November 2008. The Phase III Engage AF-TIMI 48 clinical study is an event-driven, randomised, double-blind, double-dummy,

Ulipristal acetate is an orally active selective progesterone receptor modulator that reversibly blocks the progesterone receptors in targeted tissues. HRA Pharma has been developing ulipristal acetate for a